Lou Basenese - Jan 2, 2024 Form 4 Insider Report for ENDRA Life Sciences Inc. (NDRA)

Role
Director
Signature
/s/ Lou Basenese by Mark Busch, attorney-in-fact
Stock symbol
NDRA
Transactions as of
Jan 2, 2024
Transactions value $
$0
Form type
4
Date filed
2/23/2024, 05:00 PM
Previous filing
Feb 1, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NDRA Stock Options Award $0 +600 $0.00 600 Jan 2, 2024 Common Stock 600 $1.59 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a stock option award granted on January 2, 2024 pursuant to the Issuer's Non-Employee Director Compensation Policy.
F2 This stock option award becomes exercisable in three equal annual installments beginning January 2, 2025.